Xeris Biopharma Holdings Stock Price. Everything You Need To Know About The Xeris Biopharma Holdings Stock!
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company. The company is headquartered in Chicago, Illinois and currently employs 355 full-time employees. The company went IPO on 2018-06-21. The firm is focused on improving patients’ lives by developing and commercializing products across a range of therapies. The firm has three commercial products: Gvoke, Keveyis and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. Its product candidate also includes Ogluo (EU), and Levothyroxine (XP-8121). XP-8121, is an early-stage program designed to address maintenance therapy in patients with congenital or acquired hypothyroidism who require continuous thyroid hormone replacement.
Xeris Biopharma Holdings Stock Price. Everything You Need To Know About The Xeris Biopharma Holdings Stock! performance
Xeris Biopharma Holdings is an innovative biopharmaceutical company that specializes in developing and commercializing injectable and infusible drug formulations. With a mission to improve patient care and outcomes, Xeris focuses on developing solutions for patients with diabetes, epilepsy, and other serious conditions. If you are a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, you may be wondering how to invest in Xeris Biopharma Holdings. Fortunately, with the Zorion investment platform, you can easily access and invest in this promising stock. To get started, simply create an account on the Zorion platform and complete the necessary verification process. Once your account is set up, you can explore the investment insights and recommendations provided by Zorion to make informed decisions about your investment. Additionally, Zorion offers a wide range of educational resources and materials to help you enhance your investment knowledge. Take advantage of these resources to familiarize yourself with the biopharmaceutical industry and to gain a deeper understanding of Xeris Biopharma Holdings. Investing in Xeris Biopharma Holdings from Malaysia, Thailand, Indonesia, or Vietnam has never been easier. With Zorion, you can confidently invest in this stock and potentially benefit from its growth and success in the healthcare sector. Start your investment journey today and seize new opportunities in the world of biopharmaceuticals.
